Aaron Weaver

Aaron Weaver is a managing director at Apeiron Investments which focuses on the life sciences sector. He is also the senior general counsel and supports fundraising and investor relations activities at ATAI Life Sciences AG, a clinical stage biopharmaceutical company focused on the development of therapeutics for the treatment of mood disorders, addiction and anxiety.

From 2013 to 2017, Mr Weaver was an investment banker at Credit Suisse in London within the capital markets solutions team, advising on capital structuring and issuances for a full spectrum of corporate issuers from pre-revenue companies to public listed companies. Prior to that, he was a capital markets solicitor at Allen & Overy LLP in London for 6 years.